Lecanemab received FDA approval in January after a phase 3 trial showed it slows cognitive decline in early-stage Alzheimer's ...

Biogen is set for a revenue boost thanks to the approval of Alzheimers drug Leqembi. But other companies will also benefit ...

The FDA has recently approved exciting new treatments that can slow the progression of Alzheimer’s disease, a scourge that claims more American lives than breast cancer and prostate cancer combined.

Alzheimer’s disease has killed at least three women in Astrida Schaeffer’s family over two generations, leaving her feeling helpless and bereft. The first was her Polish-born maternal ...

A potential new Alzheimer’s drug represses the harmful inflammatory response of the brain’s immune cells, reducing disease ...

Fast-track approval of three risky drugs intends to slow the disease, but evidence they benefit patients is shaky ...

USC researchers played a key role in a new treatment for Alzheimer’s disease, the first with full approval to target a suspected root cause of the condition, offering hope to those with the disease ...

An advisory committee to the U.S. Food and Drug Administration unanimously rejected a drug-and-device combination made by a Boston biotech, which the agency had already rejected twice.

The vote essentially upheld the Food and Drug Administration’s earlier rulings, with some members calling for new clinical ...

The 19-member advisory committee unanimously voted against Intarcia in the review, citing cardiovascular and kidney safety concerns.

For anyone who has or knows someone who has Alzheimer’s disease, a progressive and irreversible form of dementia that’s ultimately deadly, it can sometimes be difficult to find hope.

A CMS pilot project will test a low-cost way to help families support a suffering loved one. It’s more promising than ...